Forth, a UK company focused on personalised biomarker tracking, has attracted £1.6m (US$2.2m) in a second round of funding from a consortium of UK and overseas investors including Australia-listed, Melbourne-based…
Forth, a UK company focused on personalised biomarker tracking, has attracted £1.6m (US$2.2m) in a second round of funding from a consortium of UK and overseas investors including Australia-listed, Melbourne-based…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


